KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $965,000 | -8.1% | 256,725 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $1,050,000 | -12.1% | 256,725 | 0.0% | 0.01% | -12.5% |
Q4 2017 | $1,194,000 | -34.5% | 256,725 | 0.0% | 0.01% | -33.3% |
Q3 2017 | $1,823,000 | -1.8% | 256,725 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $1,856,000 | +17.4% | 256,725 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $1,581,000 | +5.1% | 256,725 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $1,504,000 | -10.8% | 256,725 | -19.2% | 0.01% | -9.1% |
Q3 2016 | $1,687,000 | -43.6% | 317,725 | -29.7% | 0.01% | -45.0% |
Q2 2016 | $2,990,000 | +41.7% | 451,725 | 0.0% | 0.02% | +53.8% |
Q1 2016 | $2,110,000 | +22.2% | 451,725 | +32.2% | 0.01% | +30.0% |
Q4 2015 | $1,726,000 | – | 341,725 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |